Assessment of Immunotherapy Response by Analyzing Tumor Microenvironment Alterations in Advanced Gastric Cancer: A Study Protocol

Authors:

Abstract
Introduction: Advanced gastric cancer has a poor prognosis, and reliable biomarkers for identifying patients who may benefit from immune checkpoint inhibitors (ICIs) combined with chemotherapy remain limited. Dynamic alterations in the tumor microenvironment (TME) may provide clinically useful information regarding treatment response. This study aims to investigate longitudinal TME changes in patients with advanced gastric cancer receiving ICIs plus chemotherapy and to explore their associations with treatment response. Methods: This is a prospective, single-center biomarker study in patients with advanced gastric cancer receiving ICIs plus chemotherapy. Matched tumor tissue samples from primary and/or metastatic lesions, together with peripheral blood samples, will be collected before treatment and after four cycles of combination therapy. Patients achieving complete response (CR) or partial response (PR) will be classified as the high-response group (HRG), whereas patients with progressive disease (PD) will be classified as the non-response group (NRG). Pre- and post-treatment TME alterations will be analyzed within each patient, and differences between the HRG and NRG will be compared, including tumor-infiltrating lymphocytes (TILs), H3K4me3, cytokines, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and tumor markers. Associations with programmed death-ligand 1 (PD-L1), mismatch repair (MMR), and Epstein–Barr virus-encoded RNA (EBER) status will also be explored. Conclusions: This study may identify dynamic TME-related biomarkers associated with response to ICIs combined with chemotherapy, and may provide evidence for future response-stratification strategies in advanced gastric cancer.
Funding Information
  • the Basic Research Program of Shanxi Province (202303021212365)
  • The CAPTRA-STAR Research Grant Project of the Beijing Cancer Prevention and Treatment Research Association (KY202501031)

This publication has 42 references indexed in Scilit: